Glyburide

insulin ; Homo sapiens







292 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 9463023 [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept]. 1997 Nov 1
152 15251771 Effect of adding a sulfonylurea in patients with non-insulin-dependent diabetes mellitus previously well controlled with insulin. 1997 Nov-Dec 2
153 8773160 Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects. 1996 Jan 1
154 8842604 Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. 1996 Aug 1
155 8911981 The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. 1996 Sep 1
156 8960854 NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment. 1996 Dec 1
157 9026680 [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria]. 1996 Jun 1
158 9072666 [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months]. 1996 Sep 1
159 7589855 An ATP-sensitive Cl- channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells. 1995 Dec 1
160 8846678 More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity. 1995 Oct 3
161 7988301 Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. 1994 Sep 3
162 8082525 Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. 1994 Jun 2
163 8112188 Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months. 1994 Jan 3
164 8123030 Glyburide enhances insulin gene expression and glucose-induced insulin release in isolated rat islets. 1994 Feb 28 6
165 8200602 [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy]. 1994 Apr 30 1
166 8201916 [Houssay's phenomenon in man]. 1993 2
167 8378743 Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus? 1993 Jul 2
168 8403805 Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? 1993 Sep 1
169 8454937 Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide. 1993 Apr 2
170 8511023 Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. 1993 May 4
171 1289019 Morning or bed-time insulin with or without glibenclamide in elderly type 2 diabetic patients unresponsive to oral antidiabetic agents. 1992 Dec 1
172 1547684 Combination therapy for NIDDM with biosynthetic human insulin and glyburide. 1992 Feb 5
173 1611155 Treatment of type I diabetes with a combination of glyburide and insulin. 1992 Jun 3
174 1611644 Glyburide in non-insulin-dependent diabetes: an update. 1992 Mar-Apr 4
175 1628875 Potassium channels of the insulin-secreting B cell. 1992 1
176 1660613 Sulfonylurea signal transduction. 1991 1
177 1847815 Glyburide priming of beta cells. Possible involvement of phosphoinositide hydrolysis. 1991 Mar 1 1
178 1902411 Comparative effects of diet or glibenclamide on insulin secretion and action in non-obese NIDDM. 1991 Feb 1
179 1904820 Extrapancreatic insulin effect of glibenclamide. 1991 3
180 1908182 Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus. 1991 Jun 24 1
181 1916009 Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus. 1991 Jul-Aug 1
182 1954808 Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. 1991 Aug 1
183 2110711 Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide. 1990 Jan-Mar 1
184 2115686 [Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector]. 1990 Jul 10 1
185 2117385 Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus. 1990 Aug 20 5
186 2117386 Effects of glyburide on carbohydrate metabolism and insulin action in the liver. 1990 Aug 20 4
187 2117387 Effect of glyburide on hepatic glucose metabolism. 1990 Aug 20 1
188 2117389 Effects of glyburide on in vivo insulin-mediated glucose disposal. 1990 Aug 20 3
189 2119677 Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide. 1990 Aug 1
190 2122177 Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. 1990 Nov 4
191 2123183 Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. 1990 Aug 1
192 2125460 Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin. 1990 Nov 1
193 2126639 Combined insulin-glibenclamide therapy of NIDDM patients in primary health care. A follow-up study of its compliance and efficacy and a review of the literature. 1990 Dec 1
194 2171690 Reduced glucose-6-phosphorylase and NADPH generating enzyme activities associated with glibenclamide induced hypoglycemia and hypoinsulinemia in genetically obese mice. 1990 3
195 2499443 Effects of combined insulin-sulfonylurea therapy in type II patients. 1989 Jun 1
196 2504288 Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. 1989 Aug 21 1
197 2505990 Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. 1989 Sep 1
198 2524334 How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? 1989 May-Jun 3
199 2559356 Insulin and IGF-I receptors in neuroblastoma cells: increases in mRNA and binding produced by glyburide. 1989 Oct 1
200 3126291 A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery. 1988 Jan 1